Molecular Cytogenetics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=882298, encodeId=935c882298bd, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：刚投了一篇Short Report，回顾性分析了大样本血液肿瘤染色体异常，从中筛选出几种目前较为罕见的并存重现性染色体异常，通过细胞遗传及分子细胞遗传进行验证，并追踪预后。 Received: 22 June 2020 Accepted: 10 July 2020 Published online: 19 August 2020 一审一共18天，直接接收；版面费：2790刀。投稿界面友好，编辑比较专业，审稿速度也很快，支付便捷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/f86faba8289f4dcc826b5b18d5be7f34/93029b840de149cb8eb4631f8d24c27b.jpg, createdBy=19f55217030, createdName=147707e1m52暂无昵称, createdTime=Thu Sep 03 00:11:54 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105079, encodeId=bab811050e9d9, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105080, encodeId=720911050801e, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575246, encodeId=43ff5e5246de, content=审稿速度:3.0 经验分享：4月20投的稿件，7月23号给的小修意见稿，一审相当于接近3个月，编辑提出些内容上面需要添加的问题，编辑还是挺认真的，按照要求修改8月13号修会，等结果中，不知道最终结果会是什么样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Fri Aug 23 17:43:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573486, encodeId=bed55e34865f, content=审稿速度:12.0 经验分享：2017年，1.1几分，今年1.3几，比较落魄，但好像也没有那么容易中，我投的稿件侧重细胞遗传学，不知道行不行，4月3号投稿，等了3个月一直是编辑已指派Editor assigned，7月4号终于变成under review，不知道还要等过久，也不知道能不能接受，有进展及时和大家分享吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Jul 09 09:58:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541213, encodeId=acf25412139e, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507543, encodeId=5ac250e543b1, content=投稿审阅速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 12 13:57:00 CST 2014, time=2014-11-12, status=1, ipAttribution=)]

2020-09-03 147707e1m52暂无昵称

审稿速度:1.0 | 投稿命中率:95.0
经验分享：刚投了一篇Short Report，回顾性分析了大样本血液肿瘤染色体异常，从中筛选出几种目前较为罕见的并存重现性染色体异常，通过细胞遗传及分子细胞遗传进行验证，并追踪预后。 Received: 22 June 2020 Accepted: 10 July 2020 Published online: 19 August 2020 一审一共18天，直接接收；版面费：2790刀。投稿界面友好，编辑比较专业，审稿速度也很快，支付便捷。

207 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=882298, encodeId=935c882298bd, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：刚投了一篇Short Report，回顾性分析了大样本血液肿瘤染色体异常，从中筛选出几种目前较为罕见的并存重现性染色体异常，通过细胞遗传及分子细胞遗传进行验证，并追踪预后。 Received: 22 June 2020 Accepted: 10 July 2020 Published online: 19 August 2020 一审一共18天，直接接收；版面费：2790刀。投稿界面友好，编辑比较专业，审稿速度也很快，支付便捷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/f86faba8289f4dcc826b5b18d5be7f34/93029b840de149cb8eb4631f8d24c27b.jpg, createdBy=19f55217030, createdName=147707e1m52暂无昵称, createdTime=Thu Sep 03 00:11:54 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105079, encodeId=bab811050e9d9, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105080, encodeId=720911050801e, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575246, encodeId=43ff5e5246de, content=审稿速度:3.0 经验分享：4月20投的稿件，7月23号给的小修意见稿，一审相当于接近3个月，编辑提出些内容上面需要添加的问题，编辑还是挺认真的，按照要求修改8月13号修会，等结果中，不知道最终结果会是什么样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Fri Aug 23 17:43:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573486, encodeId=bed55e34865f, content=审稿速度:12.0 经验分享：2017年，1.1几分，今年1.3几，比较落魄，但好像也没有那么容易中，我投的稿件侧重细胞遗传学，不知道行不行，4月3号投稿，等了3个月一直是编辑已指派Editor assigned，7月4号终于变成under review，不知道还要等过久，也不知道能不能接受，有进展及时和大家分享吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Jul 09 09:58:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541213, encodeId=acf25412139e, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507543, encodeId=5ac250e543b1, content=投稿审阅速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 12 13:57:00 CST 2014, time=2014-11-12, status=1, ipAttribution=)]

2021-12-28 MS54455111222

什么样的图表可以用来发文章？

125 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=882298, encodeId=935c882298bd, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：刚投了一篇Short Report，回顾性分析了大样本血液肿瘤染色体异常，从中筛选出几种目前较为罕见的并存重现性染色体异常，通过细胞遗传及分子细胞遗传进行验证，并追踪预后。 Received: 22 June 2020 Accepted: 10 July 2020 Published online: 19 August 2020 一审一共18天，直接接收；版面费：2790刀。投稿界面友好，编辑比较专业，审稿速度也很快，支付便捷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/f86faba8289f4dcc826b5b18d5be7f34/93029b840de149cb8eb4631f8d24c27b.jpg, createdBy=19f55217030, createdName=147707e1m52暂无昵称, createdTime=Thu Sep 03 00:11:54 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105079, encodeId=bab811050e9d9, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105080, encodeId=720911050801e, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575246, encodeId=43ff5e5246de, content=审稿速度:3.0 经验分享：4月20投的稿件，7月23号给的小修意见稿，一审相当于接近3个月，编辑提出些内容上面需要添加的问题，编辑还是挺认真的，按照要求修改8月13号修会，等结果中，不知道最终结果会是什么样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Fri Aug 23 17:43:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573486, encodeId=bed55e34865f, content=审稿速度:12.0 经验分享：2017年，1.1几分，今年1.3几，比较落魄，但好像也没有那么容易中，我投的稿件侧重细胞遗传学，不知道行不行，4月3号投稿，等了3个月一直是编辑已指派Editor assigned，7月4号终于变成under review，不知道还要等过久，也不知道能不能接受，有进展及时和大家分享吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Jul 09 09:58:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541213, encodeId=acf25412139e, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507543, encodeId=5ac250e543b1, content=投稿审阅速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 12 13:57:00 CST 2014, time=2014-11-12, status=1, ipAttribution=)]

2021-12-27 衣谷

一般期刊要求图表的格式是什么？

94 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=882298, encodeId=935c882298bd, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：刚投了一篇Short Report，回顾性分析了大样本血液肿瘤染色体异常，从中筛选出几种目前较为罕见的并存重现性染色体异常，通过细胞遗传及分子细胞遗传进行验证，并追踪预后。 Received: 22 June 2020 Accepted: 10 July 2020 Published online: 19 August 2020 一审一共18天，直接接收；版面费：2790刀。投稿界面友好，编辑比较专业，审稿速度也很快，支付便捷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/f86faba8289f4dcc826b5b18d5be7f34/93029b840de149cb8eb4631f8d24c27b.jpg, createdBy=19f55217030, createdName=147707e1m52暂无昵称, createdTime=Thu Sep 03 00:11:54 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105079, encodeId=bab811050e9d9, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105080, encodeId=720911050801e, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575246, encodeId=43ff5e5246de, content=审稿速度:3.0 经验分享：4月20投的稿件，7月23号给的小修意见稿，一审相当于接近3个月，编辑提出些内容上面需要添加的问题，编辑还是挺认真的，按照要求修改8月13号修会，等结果中，不知道最终结果会是什么样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Fri Aug 23 17:43:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573486, encodeId=bed55e34865f, content=审稿速度:12.0 经验分享：2017年，1.1几分，今年1.3几，比较落魄，但好像也没有那么容易中，我投的稿件侧重细胞遗传学，不知道行不行，4月3号投稿，等了3个月一直是编辑已指派Editor assigned，7月4号终于变成under review，不知道还要等过久，也不知道能不能接受，有进展及时和大家分享吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Jul 09 09:58:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541213, encodeId=acf25412139e, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507543, encodeId=5ac250e543b1, content=投稿审阅速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 12 13:57:00 CST 2014, time=2014-11-12, status=1, ipAttribution=)]

2019-08-23 99237898_40722890

审稿速度:3.0
经验分享：4月20投的稿件，7月23号给的小修意见稿，一审相当于接近3个月，编辑提出些内容上面需要添加的问题，编辑还是挺认真的，按照要求修改8月13号修会，等结果中，不知道最终结果会是什么样的

202 0

[GetPortalCommentsPageByObjectIdResponse(id=882298, encodeId=935c882298bd, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：刚投了一篇Short Report，回顾性分析了大样本血液肿瘤染色体异常，从中筛选出几种目前较为罕见的并存重现性染色体异常，通过细胞遗传及分子细胞遗传进行验证，并追踪预后。 Received: 22 June 2020 Accepted: 10 July 2020 Published online: 19 August 2020 一审一共18天，直接接收；版面费：2790刀。投稿界面友好，编辑比较专业，审稿速度也很快，支付便捷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/f86faba8289f4dcc826b5b18d5be7f34/93029b840de149cb8eb4631f8d24c27b.jpg, createdBy=19f55217030, createdName=147707e1m52暂无昵称, createdTime=Thu Sep 03 00:11:54 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105079, encodeId=bab811050e9d9, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105080, encodeId=720911050801e, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575246, encodeId=43ff5e5246de, content=审稿速度:3.0 经验分享：4月20投的稿件，7月23号给的小修意见稿，一审相当于接近3个月，编辑提出些内容上面需要添加的问题，编辑还是挺认真的，按照要求修改8月13号修会，等结果中，不知道最终结果会是什么样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Fri Aug 23 17:43:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573486, encodeId=bed55e34865f, content=审稿速度:12.0 经验分享：2017年，1.1几分，今年1.3几，比较落魄，但好像也没有那么容易中，我投的稿件侧重细胞遗传学，不知道行不行，4月3号投稿，等了3个月一直是编辑已指派Editor assigned，7月4号终于变成under review，不知道还要等过久，也不知道能不能接受，有进展及时和大家分享吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Jul 09 09:58:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541213, encodeId=acf25412139e, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507543, encodeId=5ac250e543b1, content=投稿审阅速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 12 13:57:00 CST 2014, time=2014-11-12, status=1, ipAttribution=)]

2019-07-09 99237898_40722890

审稿速度:12.0
经验分享：2017年，1.1几分，今年1.3几，比较落魄，但好像也没有那么容易中，我投的稿件侧重细胞遗传学，不知道行不行，4月3号投稿，等了3个月一直是编辑已指派Editor assigned，7月4号终于变成under review，不知道还要等过久，也不知道能不能接受，有进展及时和大家分享吧

234 0

[GetPortalCommentsPageByObjectIdResponse(id=882298, encodeId=935c882298bd, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：刚投了一篇Short Report，回顾性分析了大样本血液肿瘤染色体异常，从中筛选出几种目前较为罕见的并存重现性染色体异常，通过细胞遗传及分子细胞遗传进行验证，并追踪预后。 Received: 22 June 2020 Accepted: 10 July 2020 Published online: 19 August 2020 一审一共18天，直接接收；版面费：2790刀。投稿界面友好，编辑比较专业，审稿速度也很快，支付便捷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/f86faba8289f4dcc826b5b18d5be7f34/93029b840de149cb8eb4631f8d24c27b.jpg, createdBy=19f55217030, createdName=147707e1m52暂无昵称, createdTime=Thu Sep 03 00:11:54 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105079, encodeId=bab811050e9d9, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105080, encodeId=720911050801e, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575246, encodeId=43ff5e5246de, content=审稿速度:3.0 经验分享：4月20投的稿件，7月23号给的小修意见稿，一审相当于接近3个月，编辑提出些内容上面需要添加的问题，编辑还是挺认真的，按照要求修改8月13号修会，等结果中，不知道最终结果会是什么样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Fri Aug 23 17:43:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573486, encodeId=bed55e34865f, content=审稿速度:12.0 经验分享：2017年，1.1几分，今年1.3几，比较落魄，但好像也没有那么容易中，我投的稿件侧重细胞遗传学，不知道行不行，4月3号投稿，等了3个月一直是编辑已指派Editor assigned，7月4号终于变成under review，不知道还要等过久，也不知道能不能接受，有进展及时和大家分享吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Jul 09 09:58:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541213, encodeId=acf25412139e, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507543, encodeId=5ac250e543b1, content=投稿审阅速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 12 13:57:00 CST 2014, time=2014-11-12, status=1, ipAttribution=)]

2017-07-14 yumi_123

有点惨淡，这1.5分都保不住，日子怎么过？？

354 0

[GetPortalCommentsPageByObjectIdResponse(id=882298, encodeId=935c882298bd, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：刚投了一篇Short Report，回顾性分析了大样本血液肿瘤染色体异常，从中筛选出几种目前较为罕见的并存重现性染色体异常，通过细胞遗传及分子细胞遗传进行验证，并追踪预后。 Received: 22 June 2020 Accepted: 10 July 2020 Published online: 19 August 2020 一审一共18天，直接接收；版面费：2790刀。投稿界面友好，编辑比较专业，审稿速度也很快，支付便捷。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/f86faba8289f4dcc826b5b18d5be7f34/93029b840de149cb8eb4631f8d24c27b.jpg, createdBy=19f55217030, createdName=147707e1m52暂无昵称, createdTime=Thu Sep 03 00:11:54 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105079, encodeId=bab811050e9d9, content=什么样的图表可以用来发文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105080, encodeId=720911050801e, content=一般期刊要求图表的格式是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575246, encodeId=43ff5e5246de, content=审稿速度:3.0 经验分享：4月20投的稿件，7月23号给的小修意见稿，一审相当于接近3个月，编辑提出些内容上面需要添加的问题，编辑还是挺认真的，按照要求修改8月13号修会，等结果中，不知道最终结果会是什么样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Fri Aug 23 17:43:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573486, encodeId=bed55e34865f, content=审稿速度:12.0 经验分享：2017年，1.1几分，今年1.3几，比较落魄，但好像也没有那么容易中，我投的稿件侧重细胞遗传学，不知道行不行，4月3号投稿，等了3个月一直是编辑已指派Editor assigned，7月4号终于变成under review，不知道还要等过久，也不知道能不能接受，有进展及时和大家分享吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Jul 09 09:58:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541213, encodeId=acf25412139e, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507543, encodeId=5ac250e543b1, content=投稿审阅速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 12 13:57:00 CST 2014, time=2014-11-12, status=1, ipAttribution=)]

2014-11-12 匿名用户

投稿审阅速度很快

471 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务